SCHEMBL151496

SCHEMBL151496

O=Cc1ccc(O)c(I)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.64
▸ PTGS2 P35354 1/20 0.64
▸ RAB9A P51151 1/20 0.64
▸ ALDH1A1 P00352 5/20 0.52
▸ ALDH5A1 P51649 3/20 0.52
▸ ABAT P80404 3/20 0.52
▸ TRIM24 O15164 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ TRIM33 Q9UPN9 1/20 0.52
▸ AOX1 Q06278 1/20 0.47
▸ ERN1 O75460 4/20 0.47
▸ APP P05067 1/20 0.42
▸ XDH P47989 1/20 0.41
▸ LCK P06239 1/20 0.39
▸ TTR P02766 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31260317 0.82 KDM4E (0.64) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
SCHEMBL430962 0.82 KDM4E (0.64) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
SCHEMBL6902242 0.78 ALDH1A1 (0.46) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
Protocatechualdehyde SCHEMBL29349539 0.78 KDM4E (1.00) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
Protocatechualdehyde SCHEMBL9512877 0.78 KDM4E (1.00) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
Protocatechualdehyde SCHEMBL36350 0.78 KDM4E (1.00) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
SCHEMBL22991353 0.77 TRPA1 (0.52) KDM4EPTGS2RAB9AALDH1A1HPGD
Protocatechualdehyde SCHEMBL28071658 0.77 KDM4E (0.86) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
Protocatechualdehyde SCHEMBL4072910 0.76 KDM4E (0.95) KDM4EPTGS2RAB9AALDH1A1ALDH5A1
Protocatechualdehyde SCHEMBL27876787 0.76 KDM4E (0.95) KDM4EPTGS2RAB9AALDH1A1ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119439624-A Imine-based high-performance ultraviolet shielding photoresist and preparation method thereof 中国工程物理研究院激光聚变研究中心 2025-02-14 — — CN claimed
CN-118549570-A Detection method of 13 disinfection byproducts in sediment 上海市环境科学研究院 2024-08-27 — — CN claimed
CN-114113370-B Analysis method of aromatic halogenated disinfection byproducts in water 东南大学 2024-03-26 — — CN claimed
CN-114113370-A Analysis method of aromatic halogenated disinfection byproducts in water 东南大学 2022-03-01 — — CN claimed
CN-107759588-B Phenyl- (pyrazolo [1,5-a ] pyridine-3-yl) ketone derivative 江苏新元素医药科技有限公司 2020-10-23 — — CN claimed
US-10464886-B2 Alpha-cyano-4-hydroxy-3-iodocinnamic acid as a matrix in MALDI mass spectrometry BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2019-11-05 — — US claimed
US-20190161438-A1 Alpha-Cyano-4-Hydroxy-3-Iodocinnamic Acid as a Matrix in Maldi Mass Spectrometry Board of Trustees of Southern IIIinois University (US) 2019-05-30 — — US claimed
CN-107759588-A A kind of phenyl (base of pyrazolo [1,5 a] pyridine 3) ketone derivatives 江苏新元素医药科技有限公司 2018-03-06 — — CN claimed
WO-2001001977-A1 METHODS FOR CONTROLLING FUNGAL PATHOGENS SUMMUS GROUP LTD. (US) 2001-01-11 — — WO claimed
EP-0488860-B1 Method for the production of polyalkoxylated aromatic compounds RHONE POULENC CHIMIE (FR) 1995-10-11 — — EP claimed
EP-0423010-B1 METHOD FOR THE PRODUCTION OF ALKOXYBENZALDEHYDES RHONE-POULENC CHIMIE (FR) 1993-09-29 — — EP claimed
US-12590062-B2 PD-1/PD-L1 inhibitors GILEAD SCIENCES, INC. (US) 2026-03-31 — — US disclosed
CN-120136703-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 — — CN disclosed
CN-120136704-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 — — CN disclosed
EP-3528813-B1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ABS DEV 1 INC (US) 2025-04-16 — — EP disclosed
US-5232945-A 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives PFIZER INC. (US) 1993-08-03 — — US disclosed
EP-0533781-A1 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVES AND ANALOGS AS HYPOGLYCEMIC AGENTS. PFIZER (US) 1993-03-31 — — EP disclosed
WO-1992003425-A1 HYPOGLYCEMIC HYDROXYUREA DERIVATIVES PFIZER INC. (US) 1992-03-05 — — WO disclosed
US-5089514-A 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents PFIZER INC. (US) 1992-02-18 — — US disclosed
WO-1991019702-A1 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVES AND ANALOGS AS HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1991-12-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590062-B2 PD-1/PD-L1 inhibitors CD274, PDCD1LG2, PDCD1 KDM4E 1970/4885PTGS2 4573/4885RAB9A 2152/4885
US-20190161438-A1 Alpha-Cyano-4-Hydroxy-3-Iodocinnamic Acid as a Matrix in Maldi Mass Spectrometry INHA, COPA, HIRA KDM4E 3401/4885PTGS2 4322/4885RAB9A 3812/4885
US-10464886-B2 Alpha-cyano-4-hydroxy-3-iodocinnamic acid as a matrix in MALDI mass spectrometry INHA, COPA, HIRA KDM4E 3401/4885PTGS2 4322/4885RAB9A 3812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback